摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(hexadecyloxy)-2-ethoxy-3-iodopropane | 126614-27-5

中文名称
——
中文别名
——
英文名称
1-(hexadecyloxy)-2-ethoxy-3-iodopropane
英文别名
1-(2-Ethoxy-3-iodopropoxy)hexadecane
1-(hexadecyloxy)-2-ethoxy-3-iodopropane化学式
CAS
126614-27-5
化学式
C21H43IO2
mdl
——
分子量
454.476
InChiKey
TYONZNHBYFKONQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    9.2
  • 重原子数:
    24
  • 可旋转键数:
    20
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-甲基-4-哌啶醇1-(hexadecyloxy)-2-ethoxy-3-iodopropaneN,N-二甲基甲酰胺 为溶剂, 反应 72.0h, 以21%的产率得到CJM PIPER
    参考文献:
    名称:
    Synthesis of quaternary amine ether lipids and evaluation of neoplastic cell growth inhibitory properties
    摘要:
    Novel quaternary amine ether lipids have been synthesized and tested for inhibition of neoplastic cell proliferation with the HL-60 promyelocytic leukemia cell line. These compounds contain a positively charged quaternary amine functional group attached either directly to the glycerol backbone or at the end of an alkoxy chain. The biological testing has identified several analogues with activity equivalent to or greater than that exhibited by the reference compound in this assay, ET-18-OMe (1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine). Among the most active analogues are compounds 11, [N,N,N-triethyl-3-(hexadecyloxy)-2-ethoxy-1-propylammonium bromide] and 22 [N-[4-[3-(hexadecyloxy)-2-ethoxypropoxy]-1-butyl]pyridinium bromide], which are approximately 3 times as active as the reference standard.
    DOI:
    10.1021/jm00168a042
  • 作为产物:
    参考文献:
    名称:
    Synthesis of quaternary amine ether lipids and evaluation of neoplastic cell growth inhibitory properties
    摘要:
    Novel quaternary amine ether lipids have been synthesized and tested for inhibition of neoplastic cell proliferation with the HL-60 promyelocytic leukemia cell line. These compounds contain a positively charged quaternary amine functional group attached either directly to the glycerol backbone or at the end of an alkoxy chain. The biological testing has identified several analogues with activity equivalent to or greater than that exhibited by the reference compound in this assay, ET-18-OMe (1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine). Among the most active analogues are compounds 11, [N,N,N-triethyl-3-(hexadecyloxy)-2-ethoxy-1-propylammonium bromide] and 22 [N-[4-[3-(hexadecyloxy)-2-ethoxypropoxy]-1-butyl]pyridinium bromide], which are approximately 3 times as active as the reference standard.
    DOI:
    10.1021/jm00168a042
点击查看最新优质反应信息

文献信息

  • MORRIS-NATSCHKE, SUSAN L.;MEYER, KAREN L.;MARASCO, CANIO J. (JR);PIANTADO+, J. MED. CHEM., 33,(1990) N, C. 1812-1818
    作者:MORRIS-NATSCHKE, SUSAN L.、MEYER, KAREN L.、MARASCO, CANIO J. (JR)、PIANTADO+
    DOI:——
    日期:——
  • US5614548A
    申请人:——
    公开号:US5614548A
    公开(公告)日:1997-03-25
  • [EN] QUATERNARY AMINE CONTAINING ETHER OR ESTER LIPID DERIVATIVES AND THERAPEUTIC COMPOSITIONS
    申请人:WAKE FOREST UNIVERSITY
    公开号:WO1990004918A2
    公开(公告)日:1990-05-17
    (EN) Quaternary amine-containing ether lipid analogs of the formula R1-X-R2-N+(R3)(R4)(R5) Z- are disclosed. R1 represents a hydrophobic group and R2 represents the backbone of the molecule, with the quaternary amine being linked directly to the backbone. Pharmaceutical compositions including these compounds and methods of combating tumors with these compounds are disclosed. Also disclosed is a method of combating viral infections with both these compounds and ET-18-OMe and its analogs.(FR) L'invention concerne des analogues lipidiques d'éther contenant une amine quaternaire de la formule R1-X-R2-N+(R3)(R4)(R5) Z-. R1 représente un groupe hydrophobe et R2 représente le squelette de la molécule, l'amine quarternaire étant directement liée au squelette. L'invention concerne également des compositions pharmaceutiques comprenant ces composés ainsi que des procédés de lutte contre des tumeurs à l'aide desdits composés. Elle concerne en outre un procédé de lutte contre des infections virales à l'aide à la fois de ces composés et de ET-18-OMe ainsi que de ses analogues.
查看更多